AI-controlled platforms permit companies to change how they lead and screen clinical trials
It’s almost difficult to talk about the future of any industry without referencing artificial intelligence (AI). Regardless of whether it’s retail, health care industry, manufacturing, etc. the conversation around the advantages proceeds.
Increasingly, pharma and biotech organizations are embracing more effective, automated processes that integrate data-driven decisions and utilize predictive analytics tools. The next development of this approach to deal with cutting-edge data analytics fuses machine learning and AI.
The absolute most discussed issues incorporate drug deficiencies, clinical trials, and the opioid epidemic, all within
…
The post Pharma Industry Has A New Drug: Artificial Intelligence appeared first on World Consulting Group.